These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 30829423)

  • 1. Graft vasculopathy of vascularized composite allografts in humans: a literature review and retrospective study.
    Ng ZY; Lellouch AG; Rosales IA; Geoghegan L; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
    Transpl Int; 2019 Aug; 32(8):831-838. PubMed ID: 30829423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite Allotransplantation.
    Kollar B; Kamat P; Klein HJ; Waldner M; Schweizer R; Plock JA
    J Vasc Res; 2019; 56(4):163-180. PubMed ID: 31266018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
    Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
    Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.
    Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G
    Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Rejection Rates in Vascularized Composite Allografts: A Systematic Review of Case Reports.
    Van Dieren L; Tawa P; Coppens M; Naenen L; Dogan O; Quisenaerts T; Lancia HH; Oubari H; Dabi Y; De Fré M; Thiessen Ef F; Cetrulo CL; Lellouch AG
    J Surg Res; 2024 Jun; 298():137-148. PubMed ID: 38603944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
    Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
    Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic rejection in vascularized composite allografts.
    Mundinger GS; Drachenberg CB
    Curr Opin Organ Transplant; 2014 Jun; 19(3):309-14. PubMed ID: 24811439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining chronic rejection in vascularized composite allografts - do we have reliable surrogates to look for?
    Kanitakis J
    Curr Opin Organ Transplant; 2023 Dec; 28(6):440-445. PubMed ID: 37811863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of MHC Antigen Matching Between Donors and Recipients on Skin Tolerance of Vascularized Composite Allografts.
    Shanmugarajah K; Powell H; Leonard DA; Mallard C; Albritton A; Harrington E; Randolph MA; Farkash E; Sachs DH; Kurtz JM; Cetrulo CL
    Am J Transplant; 2017 Jul; 17(7):1729-1741. PubMed ID: 28035752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization and Desensitization in Vascularized Composite Allotransplantation.
    Moris D; Cendales LC
    Front Immunol; 2021; 12():682180. PubMed ID: 34456906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological and inflammatory mapping of vascularized composite allograft rejection processes in a rat model.
    Friedman O; Carmel N; Sela M; Abu Jabal A; Inbal A; Ben Hamou M; Krelin Y; Gur E; Shani N
    PLoS One; 2017; 12(7):e0181507. PubMed ID: 28746417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascularized composite allograft-specific characteristics of immune responses.
    Issa F
    Transpl Int; 2016 Jun; 29(6):672-81. PubMed ID: 26927941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-specific antibodies and antibody-mediated rejection in vascularized composite allotransplantation.
    Weissenbacher A; Loupy A; Chandraker A; Schneeberger S
    Curr Opin Organ Transplant; 2016 Oct; 21(5):510-5. PubMed ID: 27517505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascularized composite allograft transplant survival in miniature swine: is MHC tolerance sufficient for acceptance of epidermis?
    Cetrulo CL; Torabi R; Scalea JR; Shimizu A; Leto Barone AA; Gillon BC; Tasaki M; Leonard DA; Cormack TA; Villani V; Randolph MA; Sachs DH; Yamada K
    Transplantation; 2013 Dec; 96(11):966-74. PubMed ID: 24056624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation.
    Plock JA; Schnider JT; Schweizer R; Zhang W; Tsuji W; Waldner M; Solari MG; Marra KG; Rubin JP; Gorantla VS
    Transplantation; 2017 Jan; 101(1):e1-e11. PubMed ID: 27893612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
    Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
    Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy.
    Frank R; Molina MR; Goldberg LR; Wald JW; Kamoun M; Lal P
    Am J Clin Pathol; 2014 Dec; 142(6):809-15. PubMed ID: 25389335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic rejection in vascularized composite allotransplantation.
    Morelon E; Petruzzo P; Kanitakis J
    Curr Opin Organ Transplant; 2018 Oct; 23(5):582-591. PubMed ID: 30102615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker and surrogate development in vascularised composite allograft transplantation: Current progress and future challenges.
    Honeyman C; Stark H; Wang HC; Hester J; Issa F; Giele H
    J Plast Reconstr Aesthet Surg; 2021 Apr; 74(4):711-717. PubMed ID: 33436335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A local drug delivery system prolongs graft survival by dampening T cell infiltration and neutrophil extracellular trap formation in vascularized composite allografts.
    Arenas Hoyos I; Helmer A; Yerly A; Lese I; Hirsiger S; Zhang L; Casoni D; Garcia L; Petrucci M; Hammer SE; Duckova T; Banz Y; Montani M; Constantinescu M; Vögelin E; Bordon G; Aleandri S; Prost JC; Taddeo A; Luciani P; Rieben R; Sorvillo N; Olariu R
    Front Immunol; 2024; 15():1387945. PubMed ID: 38887281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.